Cancer and infections in sub-Saharan Africa
Main projects
In response to the COVID-19 pandemic some of our work was temporarily suspended, but, with support from the MRC we established one of the most comprehensive epidemiological studies of SARS-CoV-2 in Africa.
Population-based multidisciplinary work on Kaposi’s Sarcoma associated Herpesvirus (KSHV) is a cornerstone of our activity and is unique on the continent. Kaposi’s Sarcoma (KS) remains one of the most common cancers in sub-Saharan Africa (SSA), and the underlying necessary cause (KSHV), is highly prevalent.
We conduct novel research on haematological malignancies/abnormalities in Africa that links to activity in the UK. It is changing long-held paradigms concerning the geographical distribution of disease and is enhancing our understanding of pathophysiology, including for the common childhood cancer Burkitt lymphoma.
We have developed strong collaborations for the study of important cancer-causing infections in Uganda: Human papillomavirus (HPV), Helicobacter pylori and Hepatitis Viruses. Much of this work has evolved into significantly larger multi-country investigations.